Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01292772 · ClinicalTrials.gov registry record
The Effects of Radiation in Reconstructed Breasts
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 12
- Enrollment target
NCT01292772 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 12 participants.
The verdict
NCT01292772 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The primary objective of this study is to use LR imaging to evaluate the effects of adjuvant radiation therapy on reconstructed breasts.
Interventions
- PROCEDURE contract-enhanced MRI
- RADIATION Unilateral Adjuvant Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-12 |
| Est. Completion | 2019-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01292772
The ClinicalTrials.gov registry entry for NCT01292772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which contract-enhanced MRI is the first listed.
NCT01292772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01292772 about?
NCT01292772 is a clinical study titled "The Effects of Radiation in Reconstructed Breasts". The primary objective of this study is to use LR imaging to evaluate the effects of adjuvant radiation therapy on reconstructed breasts.
What is the current status of trial NCT01292772?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2010-12. Estimated completion is 2019-05-05.
What interventions are being tested in trial NCT01292772?
The interventions under investigation include: contract-enhanced MRI (PROCEDURE), Unilateral Adjuvant Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01292772?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.